{"id":"https://openalex.org/W1971248628","doi":"https://doi.org/10.1177/00912700122010401","title":"The Bioavailability of the Novel Nonnucleoside Reverse Transcriptase Inhibitor GW420867X Is Unaffected by Food in Healthy Male Volunteers","display_name":"The Bioavailability of the Novel Nonnucleoside Reverse Transcriptase Inhibitor GW420867X Is Unaffected by Food in Healthy Male Volunteers","publication_year":2001,"publication_date":"2001-05-01","ids":{"openalex":"https://openalex.org/W1971248628","doi":"https://doi.org/10.1177/00912700122010401","mag":"1971248628","pmid":"https://pubmed.ncbi.nlm.nih.gov/11361049"},"language":"en","primary_location":{"id":"doi:10.1177/00912700122010401","doi":"https://doi.org/10.1177/00912700122010401","is_oa":false,"landing_page_url":"https://doi.org/10.1177/00912700122010401","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064099926","display_name":"Lindsey Cass","orcid":"https://orcid.org/0000-0003-3719-0883","observed_orcids":["https://orcid.org/0000-0003-3719-0883"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Lindsey M. Cass","raw_affiliation_strings":["Department of Clinical Pharmacology, Glaxo Wellcome Research and Development, Glaxo Wellcome, Greenford, Middlesex, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Glaxo Wellcome Research and Development, Glaxo Wellcome, Greenford, Middlesex, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111754267","display_name":"Katy H. P. Moore","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katy H. P. Moore","raw_affiliation_strings":["Department of Clinical Pharmacology, Glaxo Wellcome Research and Development, Glaxo Wellcome, Greenford, Middlesex, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Glaxo Wellcome Research and Development, Glaxo Wellcome, Greenford, Middlesex, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045220307","display_name":"Nigel S. Dallow","orcid":"https://orcid.org/0000-0002-1678-0561","observed_orcids":["https://orcid.org/0000-0002-1678-0561"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nigel S. Dallow","raw_affiliation_strings":["Department of Clinical Pharmacology, Glaxo Wellcome Research and Development, Glaxo Wellcome, Greenford, Middlesex, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Glaxo Wellcome Research and Development, Glaxo Wellcome, Greenford, Middlesex, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103392584","display_name":"Anne E. Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086142","display_name":"Zimmer Biomet (United Kingdom)","ror":"https://ror.org/00mke2t69","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210086142","https://openalex.org/I4210115238"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anne E. Jones","raw_affiliation_strings":["International Development Support, Biomet, Glaxo Wellcome Research and Development, Ware, Herts, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Development Support, Biomet, Glaxo Wellcome Research and Development, Ware, Herts, United Kingdom","institution_ids":["https://openalex.org/I4210086142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016424516","display_name":"Jonathan R. Sisson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802052328","display_name":"Northwick Park Hospital","ror":"https://ror.org/030j6qm79","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800484787","https://openalex.org/I2802052328"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jonathan R. Sisson","raw_affiliation_strings":["Glaxo Wellcome Clinical Pharmacology Unit (Study Site), Northwick Park Hospital, Harrow, Middlesex, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxo Wellcome Clinical Pharmacology Unit (Study Site), Northwick Park Hospital, Harrow, Middlesex, United Kingdom","institution_ids":["https://openalex.org/I2802052328"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022472681","display_name":"William Prince","orcid":"https://orcid.org/0009-0000-5341-6382","observed_orcids":["https://orcid.org/0009-0000-5341-6382"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William T. Prince","raw_affiliation_strings":["Department of Clinical Pharmacology, Glaxo Wellcome Research and Development, Glaxo Wellcome, Greenford, Middlesex, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Glaxo Wellcome Research and Development, Glaxo Wellcome, Greenford, Middlesex, United Kingdom","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5064099926"],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.2455,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.56414582,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"41","issue":"5","first_page":"528","last_page":"535"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.014999999664723873,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.9580000042915344},{"id":"https://openalex.org/keywords/food-effect","display_name":"food effect","score":0.7829999923706055},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.9229999780654907},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9629999995231628},{"id":"https://openalex.org/keywords/high-fat-meal","display_name":"high-fat meal","score":0.9010000228881836},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.49399998784065247},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.8629999756813049}],"concepts":[{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.9288949966430664},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.852060079574585},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7102973461151123},{"id":"https://openalex.org/C2778345441","wikidata":"https://www.wikidata.org/wiki/Q6460735","display_name":"Meal","level":2,"score":0.6779735088348389},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.6153930425643921},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.513107419013977},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49679329991340637},{"id":"https://openalex.org/C193230392","wikidata":"https://www.wikidata.org/wiki/Q1663054","display_name":"Ingestion","level":2,"score":0.4222058951854706},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.421680212020874},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.42084386944770813},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3497554659843445},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.09037706255912781},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.08498021960258484},{"id":"https://openalex.org/C2776452011","wikidata":"https://www.wikidata.org/wiki/Q311463","display_name":"Sida","level":4,"score":0.06347885727882385},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.06282129883766174}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004041","descriptor_name":"Dietary Fats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005767","descriptor_name":"Gastrointestinal Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006261","descriptor_name":"Headache","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D016001","descriptor_name":"Confidence Intervals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016018","descriptor_name":"Least-Squares Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018565","descriptor_name":"Food-Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/00912700122010401","doi":"https://doi.org/10.1177/00912700122010401","is_oa":false,"landing_page_url":"https://doi.org/10.1177/00912700122010401","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:11361049","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11361049","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical pharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W8481647","https://openalex.org/W1494510785","https://openalex.org/W1614413167","https://openalex.org/W1969836247","https://openalex.org/W1987972580","https://openalex.org/W2001549315","https://openalex.org/W2001607160","https://openalex.org/W2022547997","https://openalex.org/W2037639862","https://openalex.org/W2063020803","https://openalex.org/W2068613673","https://openalex.org/W2068705423","https://openalex.org/W2087464705","https://openalex.org/W2110123751","https://openalex.org/W2120711252","https://openalex.org/W2149568397","https://openalex.org/W2325343629","https://openalex.org/W4298345797","https://openalex.org/W4299570440"],"related_works":["https://openalex.org/W2131499894","https://openalex.org/W2460818445","https://openalex.org/W1968644601","https://openalex.org/W2016724972","https://openalex.org/W2540270577","https://openalex.org/W1576188396","https://openalex.org/W1966965175","https://openalex.org/W4309845732","https://openalex.org/W2076764692","https://openalex.org/W2149148741"],"abstract_inverted_index":{"The":[0,62,88,141],"effect":[1],"of":[2,7,27,45,79,81,101,115,143,154],"food":[3,116,155],"on":[4,117],"the":[5,34,74,77,106,110],"bioavailability":[6,142],"GW420867X,":[8],"a":[9,38,43],"novel":[10],"nonnucleoside":[11],"reverse":[12],"transcriptase":[13],"inhibitor,":[14],"was":[15,31,83,95,121,145],"investigated":[16],"in":[17,33],"15":[18],"young,":[19],"healthy,":[20],"male":[21],"volunteers.":[22],"A":[23],"single":[24],"oral":[25],"dose":[26],"GW420867X":[28,82,118,120,144,149],"100":[29],"mg":[30],"administered":[32,152],"fasted":[35,107],"state,":[36],"after":[37,42],"high-fat":[39],"meal,":[40],"and":[41,50,57,156],"meal":[44],"normal":[46],"fat":[47,157],"composition.":[48],"Tolerability":[49],"pharmacokinetic":[51],"sampling":[52],"were":[53,70,125,135],"assessed":[54],"at":[55],"baseline":[56],"up":[58],"to":[59,91,97,139],"600":[60],"hours.":[61],"median":[63,89],"concentration-time":[64],"plots":[65],"for":[66],"each":[67],"treatment":[68,108],"group":[69],"essentially":[71],"superimposable.":[72],"Neither":[73],"rate":[75],"nor":[76],"extent":[78],"absorption":[80],"significantly":[84],"affected":[85],"by":[86,147],"food.":[87,148],"time":[90],"peak":[92],"plasma":[93],"concentration":[94],"3":[96],"4":[98],"hours,":[99],"irrespective":[100],"treatment.":[102],"Pairwise":[103],"comparisons":[104],"using":[105],"as":[109,137],"comparator":[111],"showed":[112],"no":[113,126],"impact":[114],"pharmacokinetics.":[119],"well":[122],"tolerated.":[123],"There":[124],"serious":[127],"or":[128],"treatment-limiting":[129],"adverse":[130],"events;":[131],"all":[132],"episodes":[133],"reported":[134],"rated":[136],"mild":[138],"moderate.":[140],"unaffected":[146],"may":[150],"be":[151],"independently":[153],"intake.":[158]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}